Aggressive differentiated thyroid cancer with multiple metastases and NRAS and TERT promoter mutations: A case report
Fabiana Pani et al, 2017, Oncology Letters CrossRef
TERTp mutation is associated with a shorter progression free survival in patients with aggressive histology subtypes of follicular-cell derived thyroid carcinoma
Gustavo C. Penna et al, 2018, Endocrine CrossRef
Thyroglobulin in differentiated thyroid cancer
Carol Evans et al, 2015, Clinica Chimica Acta CrossRef
Thyroid Dysfunction in Patients with Metastatic Carcinoma Treated with Sunitinib: Is Thyroid Autoimmunity Involved?
Fabiana Pani et al, 2015, Thyroid CrossRef
Regorafenib-induced hypothyroidism and cancer-related fatigue: is there a potential link?
Fabiana Pani et al, 2017, European Journal of Endocrinology CrossRef
Predicting 131I-avidity of metastases from differentiated thyroid cancer using 18F-FDG PET/CT in postoperative patients with elevated thyroglobulin
Min Liu et al, 2018, Scientific Reports CrossRef
Evaluation of Clinical Outcomes of Antiangiogenic-Targeted Therapy in Patients with Pulmonary Metastatic Renal Cell Carcinoma Using Non–Contrast-Enhanced Computed Tomography
Guang-yu Wu et al, 2014, Academic Radiology CrossRef
Sorafenib: is a partial response and stabilization of disease greater than 70% a modest response?
Fabián Pitoia, 2014, Endocrine-Related Cancer CrossRef
Management of Distant Metastasis in Differentiated Thyroid Cancer
David A. Pattison et al, 2018, Evidence-Based Endocrine Surgery CrossRef
Comparison of the RECIST 1.0 and RECIST 1.1 in patients treated with targeted agents: a pooled analysis and review
Jung Han Kim, 2016, Oncotarget CrossRef
Investigating the impact of target lesion selection on drug effect evaluation and tumour growth rate determination using tumour growth inhibition models: Example of malignant pleural mesothelioma patients treated with cisplatin alone or in combination with pemetrexed
Aurélie Lombard et al, 2021, European Journal of Pharmaceutical Sciences CrossRef